R-FND
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for R-FND, covering 2022-04-22 to 2022-04-22. Get the full timeline:
Most recent: Clinical Trial Update: Rituximab, Fludarabine, Mitoxantrone, Dexamethasone (R-FND) Plus Zevalin for High-Risk Follicular Lymphoma [Phase 2]